336 related articles for article (PubMed ID: 31085953)
21. The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectives.
Schubert-Bast S; Rosenow F; Klein KM; Reif PS; Kieslich M; Strzelczyk A
Epilepsy Behav; 2019 Feb; 91():94-98. PubMed ID: 29941212
[TBL] [Abstract][Full Text] [Related]
22. The role of somatic mutational events in the pathogenesis of epilepsy.
Iffland PH; Crino PB
Curr Opin Neurol; 2019 Apr; 32(2):191-197. PubMed ID: 30762606
[TBL] [Abstract][Full Text] [Related]
23. Role of the mTOR signaling pathway in epilepsy.
Meng XF; Yu JT; Song JH; Chi S; Tan L
J Neurol Sci; 2013 Sep; 332(1-2):4-15. PubMed ID: 23773767
[TBL] [Abstract][Full Text] [Related]
24. Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy.
Wang X; Sha L; Sun N; Shen Y; Xu Q
Mol Neurobiol; 2017 Jan; 54(1):175-187. PubMed ID: 26732600
[TBL] [Abstract][Full Text] [Related]
25. GATOR1 complex: the common genetic actor in focal epilepsies.
Baldassari S; Licchetta L; Tinuper P; Bisulli F; Pippucci T
J Med Genet; 2016 Aug; 53(8):503-10. PubMed ID: 27208208
[TBL] [Abstract][Full Text] [Related]
26. Somatic variants in new candidate genes identified in focal cortical dysplasia type II.
Zhang Z; Gao K; Liu Q; Zhou J; Li X; Lang N; Liu M; Wang T; Zhang J; Wang H; Dong Y; Ji T; Wang S; Liu X; Jiang Y; Cai L; Wu Y
Epilepsia; 2020 Apr; 61(4):667-678. PubMed ID: 32216069
[TBL] [Abstract][Full Text] [Related]
27. DEPDC5 as a potential therapeutic target for epilepsy.
Myers KA; Scheffer IE
Expert Opin Ther Targets; 2017 Jun; 21(6):591-600. PubMed ID: 28406046
[TBL] [Abstract][Full Text] [Related]
28. mTOR signaling in epilepsy: insights from malformations of cortical development.
Crino PB
Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
[TBL] [Abstract][Full Text] [Related]
29. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
30. The mTOR pathway genes
Nguyen LH; Xu Y; Nair M; Bordey A
Elife; 2024 Feb; 12():. PubMed ID: 38411613
[TBL] [Abstract][Full Text] [Related]
31. Focal malformations of cortical development: new vistas for molecular pathogenesis.
Lim KC; Crino PB
Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
[TBL] [Abstract][Full Text] [Related]
32. mTOR dysregulation and tuberous sclerosis-related epilepsy.
Curatolo P; Moavero R; van Scheppingen J; Aronica E
Expert Rev Neurother; 2018 Mar; 18(3):185-201. PubMed ID: 29338461
[TBL] [Abstract][Full Text] [Related]
33. Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway.
Zeng LH; Rensing NR; Wong M
Mol Cell Pharmacol; 2009 Jan; 1(3):124-129. PubMed ID: 20419051
[TBL] [Abstract][Full Text] [Related]
34. DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.
Iffland PH; Baybis M; Barnes AE; Leventer RJ; Lockhart PJ; Crino PB
Neurobiol Dis; 2018 Jun; 114():184-193. PubMed ID: 29481864
[TBL] [Abstract][Full Text] [Related]
35. Recent advances and limitations of mTOR inhibitors in the treatment of cancer.
Ali ES; Mitra K; Akter S; Ramproshad S; Mondal B; Khan IN; Islam MT; Sharifi-Rad J; Calina D; Cho WC
Cancer Cell Int; 2022 Sep; 22(1):284. PubMed ID: 36109789
[TBL] [Abstract][Full Text] [Related]
36. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of the Ketogenic Diet for Pediatric Epilepsy According to the Presence of Detectable Somatic mTOR Pathway Mutations in the Brain.
Ko A; Sim NS; Choi HS; Yang D; Kim SH; Lee JS; Kim DS; Lee JH; Kim HD; Kang HC
J Clin Neurol; 2022 Jan; 18(1):71-78. PubMed ID: 35021279
[TBL] [Abstract][Full Text] [Related]
38. Rapamycin provides anti-epileptogenic effect in a rat model of post-traumatic epilepsy via deactivation of mTOR signaling pathway.
Wang F; Chen F; Wang G; Wei S; Fang F; Kang D; Lin Y
Exp Ther Med; 2018 Jun; 15(6):4763-4770. PubMed ID: 29904395
[TBL] [Abstract][Full Text] [Related]
39. Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components.
Saxena A; Sampson JR
Semin Cell Dev Biol; 2014 Dec; 36():140-6. PubMed ID: 25263008
[TBL] [Abstract][Full Text] [Related]
40. mTOR inhibition in epilepsy: rationale and clinical perspectives.
Ostendorf AP; Wong M
CNS Drugs; 2015 Feb; 29(2):91-9. PubMed ID: 25633849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
